Line | |||||
---|---|---|---|---|---|
Measure | Sample size | ND3-L | PHA-L | CC-L | Control |
Trait under selection | |||||
ND3 | 48 | 6.10 ± 1.85a | 2.60 ± 1.22b | 1.75 ± 1.26c | 2.68 ± 1.36b |
PHA | 48 | 1.20 ± 0.86b | 1.87 ± 0.68a | 1.33 ± 0.53b | 1.43 ± 0.74b |
CC | 48 | 0.33 ± 0.08a | 0.17 ± 0.04b | ||
Before immunization with M.B. (d 0) | |||||
M.B. | 50 | 6.27 ± 1.67a | 5.07 ± 1.47b | 4.64 ± 1.55b | 5.13 ± 1.13b |
LPS | 50 | 1.57 ± 1.54 | 1.45 ± 1.49 | 1.31 ± 1.65 | 2.08 ± 1.71 |
LTA | 50 | 5.14 ± 1.68a | 4.46 ± 1.43b | 3.92 ± 1.70b | 4.17 ± 1.75b |
Anti-Gal | 50 | 11.96 ± 2.98b | 10.81 ± 2.68b | 13.72 ± 5.81a | 11.61 ± 3.17b |
After immunization with M.B.(d 11) | |||||
M.B. | 50 | 7.73 ± 1.69a | 7.19 ± 1.34a | 6.29 ± 1.46b | 6.50 ± 1.07b |
LPS | 49 | 2.53 ± 1.54a | 2.26 ± 1.36ab | 1.73 ± 1.65b | 2.77 ± 1.82a |
LTA | 48 | 6.44 ± 1.54a | 5.91 ± 1.17ab | 5.55 ± 1.51b | 5.51 ± 1.58b |
Anti-Gal | 50 | 16.48 ± 3.55a | 14.60 ± 2.66b | 13.72 ± 3.79bc | 12.82 ± 3.02c |
Analysis of variance | |||||
Line | Sex | Interaction | R 2 | ||
Trait under selection | |||||
ND3 | 48 | *** | ns | ns | 0.84 |
PHA | 48 | ** | ns | ns | 0.71 |
CC | 48 | *** | ns | ns | 0.78 |
Before immunization with M.B. (d 0) | |||||
M.B. | 50 | *** | *** | ns | 0.68 |
LPS | 50 | ns | ns | ns | 0.53 |
LTA | 50 | * | ns | ns | 0.69 |
Anti-Gal | 50 | ** | *** | *** | 0.82 |
After immunization with M.B. (d 11) | |||||
M.B. | 50 | *** | ns | ns | 0.61 |
LPS | 49 | * | ns | ns | 0.57 |
LTA | 48 | * | ns | ns | 0.68 |
Anti-Gal | 50 | *** | *** | ns | 0.77 |
Responsiveness (d 11-d 0) | |||||
M.B. | 50 | * | *** | ns | 0.72 |
LPS | 50 | ns | * | ns | 0.61 |
LTA | 50 | ns | ** | ns | 0.69 |
Anti-Gal | 50 | *** | *** | *** | 0.96 |